To further investigate the potential functions of CD56 in ccRCC cell lines, we generated CD56 stable knockout (CD56-KO) cells using the human ccRCC 786-O cells by CRISPR/Cas9 genome editing technique. The gene discussed is NCAM1; the disease is nonpapillary renal cell carcinoma.